Government ❯Regulation ❯Health Regulation

FDA

Emergency Use Authorization MDMA Approval FDA Enforcement Actions Vaccine Approval Process

FDA Rejects Aldeyra's Reproxalap NDA for Dry Eye Disease Over Efficacy Issues

The decision marks the second rejection of the drug application, with Aldeyra planning a mid-2025 resubmission pending new trial results.

FDA Faces Critical Decision on MDMA Therapy for PTSD